By Dave Doolittle
BOSTON—Increasing interactions between clinical specialty pharmacists and patients taking oral chemotherapy can help healthcare facilities better assess medication adherence and patient-reported outcomes (PROs), a pilot program at Massachusetts General Hospital (MGH) shows.
The eight-month pilot, which involved 19 patients on oral chemotherapy for various forms of leukemia, also strengthened communication between patients, physicians, specialty pharmacists dispensing oral